More than 100 candidates have joined the search for the corona vaccine, but Oxford University has the highest hopes for a successful vaccine. The vaccine trial, led by Professor Sara Gilbert, was a huge success on Friday. You will be happy to know that the first phase of the Human Trial has been successfully passed and the second and third phases are being launched soon. The vaccine is called ChAdOx1 nCoV-19.
People in 2 groups were given 2 different vaccines
Sara Gilbert, a professor of vaccineology, said she recruited 1,000 volunteers between the ages of 18 and 55 in the first phase of the human trial. All of these people were divided into 2 groups, then tested on 2 different vaccines. However, the volunteers were not told what vaccine they had been given.
Preparations for the second and third phases begin
The second and third phases of the vaccine trial are now being prepared. The first phase will involve a small number of children aged 5 to 12, youth and 10,260 people aged 56 to 69. In this way, researchers will evaluate the effect of the vaccine on people of different ages. The third phase of the vaccine trial on humans will involve a large number of 18-year-olds. In this, researchers will see how effective this vaccine is for the treatment of corona virus.
Corona vaccine to reach the world by September!
In the second and third phases of the vaccine trial, all volunteers in the group will be given one or two doses of ChAdOx1 nCoV-19 and the licensed vaccine MenACWY. The test will be like a ‘blind game’ in which volunteers are not told what vaccine they have been given. Earlier, Sara Gilbert said she had high hopes for the trial. He also said that if he succeeds in vaccine trials, the world could get the first vaccine against the corona virus by September.
